31P Magnetic Resonance Spectroscopic Imaging of brain tumours

31P Magnetic Resonance Spectroscopic Imaging of brain tumours - 31P MRSI of brain tumours

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32708

Enrollment

Registered

2008-12-15

Start date

2008-09-30

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hersen tumoren brain tumour glial tumour

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with a glial tumour and without MRI contra-indication

Exclusion criteria

Exclusion criteria: patients with MRI contra-indication. patients that are claustrofobic. Patients with pacemakers or neurostimulators. Patients with large metal implants

Design outcomes

Primary

Measure	Time frame
In this study we try to characterise the phosphoester content in brain tumours. The main study parameters are the peak areas of the (glycerol)choline and (glycerol)ethanolamine in the 31P MR spectrum.	—

Secondary

Measure	Time frame
1H MRS spectra.	—

Countries

Netherlands

Outcome results